Eva Regina Haspinger

598 total citations
13 papers, 403 citations indexed

About

Eva Regina Haspinger is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Eva Regina Haspinger has authored 13 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Eva Regina Haspinger's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eva Regina Haspinger is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eva Regina Haspinger collaborates with scholars based in Italy, United States and Australia. Eva Regina Haspinger's co-authors include Marina Chiara Garassino, Eva Surmacz, Filippo de Braud, Nicoletta Zilembo, Francesco Gelsomino, Francesca La Russa, Daniel Knappe, Sándor Lovas, Ralf Hoffmann and Marco Cassone and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Cancer Treatment Reviews.

In The Last Decade

Eva Regina Haspinger

13 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Regina Haspinger Italy	8	151	128	121	120	60	13	403
Osman Manavoğlu Türkiye	13	179 1.2×	97 0.8×	75 0.6×	87 0.7×	57 0.9×	27	333
Wei‐Hwa Lee Taiwan	11	123 0.8×	86 0.7×	87 0.7×	209 1.7×	86 1.4×	26	464
Yingying Huang China	9	106 0.7×	60 0.5×	47 0.4×	106 0.9×	39 0.7×	30	326
Alessio Degiovanni Italy	12	107 0.7×	85 0.7×	44 0.4×	121 1.0×	70 1.2×	23	345
Anand Rajan United States	14	119 0.8×	57 0.4×	93 0.8×	228 1.9×	125 2.1×	49	548
Yanli Yan China	8	179 1.2×	118 0.9×	46 0.4×	118 1.0×	38 0.6×	20	479
Alessandra Cocomazzi Italy	11	106 0.7×	72 0.6×	74 0.6×	116 1.0×	48 0.8×	17	363
Makoto Edagawa Japan	10	87 0.6×	103 0.8×	59 0.5×	117 1.0×	42 0.7×	28	329
Xueyan Wang China	14	135 0.9×	123 1.0×	32 0.3×	169 1.4×	57 0.9×	33	505
Kazuyuki Koike Japan	13	65 0.4×	69 0.5×	82 0.7×	166 1.4×	66 1.1×	29	391

Countries citing papers authored by Eva Regina Haspinger

Since Specialization

Citations

This map shows the geographic impact of Eva Regina Haspinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Regina Haspinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Regina Haspinger more than expected).

Fields of papers citing papers by Eva Regina Haspinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Regina Haspinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Regina Haspinger. The network helps show where Eva Regina Haspinger may publish in the future.

Co-authorship network of co-authors of Eva Regina Haspinger

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Regina Haspinger. A scholar is included among the top collaborators of Eva Regina Haspinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Regina Haspinger. Eva Regina Haspinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Giorgi, Carlo Alberto, Stefania Russo, Linda Nicolardi, et al.. (2022). Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. Critical Reviews in Oncology/Hematology. 180. 103848–103848. 6 indexed citations

Bluthgen, M.V., Caroline Caramella, Laurence Faivre, et al.. (2015). 3127 Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 51. S645–S646. 4 indexed citations

Haspinger, Eva Regina, Laurent Dercle, B. Besse, et al.. (2015). 467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01. European Journal of Cancer. 51. S101–S101. 2 indexed citations

Caramella, Caroline, M.V. Bluthgen, Charles Leduc, et al.. (2015). 3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 51. S647–S648. 7 indexed citations

Serpico, Danila, Annalisa Trama, Eva Regina Haspinger, et al.. (2014). Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors. Annals of Oncology. 26(5). 838–847. 17 indexed citations

Haspinger, Eva Regina, Francesco Agustoni, Valter Torri, et al.. (2014). Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations. Critical Reviews in Oncology/Hematology. 94(2). 213–227. 41 indexed citations

Pessi, M.A., Nicoletta Zilembo, Eva Regina Haspinger, et al.. (2013). Targeted therapy-induced diarrhea: A review of the literature. Critical Reviews in Oncology/Hematology. 90(2). 165–179. 39 indexed citations

Agustoni, Francesco, Marco Platania, Milena Vitali, et al.. (2013). Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders. Cancer Treatment Reviews. 40(1). 197–203. 38 indexed citations

Gelsomino, Francesco, Francesco Facchinetti, Eva Regina Haspinger, et al.. (2013). Targeting the MET gene for the treatment of non-small-cell lung cancer. Critical Reviews in Oncology/Hematology. 89(2). 284–299. 62 indexed citations

10.

Pusceddu, Sara, Milena Vitali, Eva Regina Haspinger, et al.. (2013). Update on Therapeutic Strategy in Lung Carcinoids. Journal of Cancer Therapy. 4(10). 1466–1471. 1 indexed citations

11.

Pelosi, Giuseppe, Eva Regina Haspinger, Giorgia Leone, et al.. (2013). Does Immunohistochemistry Affect Response to Therapy and Survival of Inoperable Non–Small Cell Lung Carcinoma Patients? A Survey of 145 Stage III-IV Consecutive Cases. International Journal of Surgical Pathology. 22(2). 136–148. 8 indexed citations

12.

Ferla, Rita, Eva Regina Haspinger, & Eva Surmacz. (2012). Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncology Letters. 4(5). 1077–1081. 29 indexed citations

13.

Ötvös, László, Eva Regina Haspinger, Francesca La Russa, et al.. (2011). Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnology. 11(1). 90–90. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact